Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source. 


The Vera and Joseph Dresner Foundation  MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP). 

The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards 
- Established Investigator Awards

Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis. 
Learn More>> 

Russell Sage Foundation (RSF) Decision Making and Human Behavior in Context Initiative
The Russell Sage Foundation (RSF) is launching a new special initiative on Decision Making and Human Behavior in Context that will support innovative research on decision making across the social sciences that examines causes, consequences, processes, or context from a behavioral or alternative perspective. We seek to support a wide range of research on decision-making in context by scholars in psychology, political science, sociology, and other social science fields who are pursuing questions consistent with the aims of the Foundation.

Letter of Intent Deadline: August 21, 2019
Learn More>>

Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care 
National Comprehensive Cancer Network® (NCCN®) is pleased to announce that it is collaborating with Pfizer Global Medical Grants (Pfizer) to offer a new grant opportunity for improving care for patients with metastatic breast cancer (MBC). The intent of this RFP is to encourage investigators at NCCN Member Institutions to submit proposals describing concepts for developing best practices and collaborative oncology care models between academic centers and referring community providers. The overarching goal is to leverage the expertise and resources of NCCN-designated cancer centers to improve quality and outcomes across the continuum of care for all MBC patients.

Proposal Deadline:
11:59 PM ET, August 28, 2019

Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1)
Through this FOA, the National Cancer Institute (NCI) proposes and will support the Cancer Prevention Clinical Trials Network (CP-CTNet).

Application Deadline: August 29, 2019
Learn more about the CP-CTNet Award>>

Wellcome Innovator Awards
These awards support researchers who are transforming great ideas into healthcare innovations that could have a significant impact on human health. The work you propose must be essential for developing your healthcare innovation.

Application Deadline: August 30, 2019
Learn More>>

Novel Technology Tools to Facilitate Research Using Next Generation Patient-derived Cancer Models (U01)

Through this FOA, the NCI will support the development of technology tools that will facilitate, accelerate, and/or enhance research using advanced human-derived next generation cancer models, such as organoids, conditionally reprogrammed cells, and others.

Application Deadline: August 30, 2019

Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) 
This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the scholar can be considered to remain as an investigator within the intramural program.

Application Deadline: August 30, 2019, by 5:00 PM 
Learn More>>

The Elsa U. Pardee Foundation Research Grant
The Elsa U. Pardee Foundation funds research to investigators in United States non-profit institutions proposing research directed toward identifying new treatments or cures for cancer. The Foundation funds projects for a one year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified.

Application Deadline:
August 31, 2019
Learn More>>

Mizutani Foundation for Glycoscience - The 27th Research Grant (for 2020)
The objective of the Foundation is to promote world-wide progress in glycoscience. In accordance with this objective, the Foundation provides research grants to outstanding proposals for basic and applied studies on glycoconjugate in the fields of organic chemistry, biochemistry, biophysics, molecular biology, cellular biology and medical sciences.
Application Deadline: September 1, 2019** (in Tokyo, Japan (13 hours ahead from EST))
Learn More>>

Concern Foundation - The Conquer Cancer Now Award
Concern Foundation is an independent, volunteer-driven organization conceived in 1968 by a group of friends who wanted to make sure their dollars counted in the fight against cancer. With an average of 92% or greater of net proceeds going directly to research, Concern has raised more than $60 million dollars and funded over 750 cancer research scientists studying cancer, primarily in the areas of cancer genetics, cancer cell biology, and cancer immunology. By specifically targeting promising early-career scientists and providing critically needed “seed” money for innovative projects, Concern Foundation supports development of the next generation of cancer researchers and thus promotes progress in understanding cancer biology and improved approaches to cancer.

Proposals must be hypothesis-driven and centered on cancer genetics, cancer biology, or cancer immunology. Concern will not fund clinical trials, cancer epidemiology, or behavioral studies.

Application Deadline: September 5, 2019
Learn More>>

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44)

This FOA encourages Small Business Innovation Research grant applications from small business concerns proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries, and low-resource settings in the US.

Application Deadline: September 5, 2019
Learn more about this SBIR Grant>>

Gilead Sciences Research Scholars Program in Hematology/Oncology 
This program supports innovative scientific research that will advance knowledge in the field of Hematology/Oncology and provide support for research career development. The awards provide financial support to 3 junior faculty researchers in Canada or the United States a for a 2- year period. 

Application Deadline: September 6, 2019 
Learn more about the Gilead Scholars Program>>

The Eppley Foundation for Research
The Eppley Foundation for Research was incorporated in 1947 for the purpose of "increasing knowledge in pure or applied science... in chemistry, physics, and biology through study, research, and publication." The Eppley Foundation supports advanced, novel, scientific research by PhDs or MDs with an established record of publication in their specialties. Candidates with newly awarded doctorates occasionally, but rarely, meet the Foundation's requirements for advanced research.  

Letter of Intent Deadline: September 15, 2019 
Learn More>>

National Cancer Institute Youth Enjoy Science Research Education Program (R25) 
The over-arching goal of this NCI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce.   

Application Deadline: September 25, 2019
Learn more about this NCI R25 Program>>

Susan G. Komen Career Catalyst Research Grant 
The topic area for the FY20 Career Catalyst Research Award is Redefining Metastatic Breast Cancer through Liquid Biopsy. The goal of this focus area is to support outstanding research seeking to use liquid biopsy techniques to improve treatment, detection, and understanding of metastatic breast cancer which will lead to a reduction in breast cancer deaths by 2026. Komen requests Letters of Intent for research projects that address one of the following focus areas: 
  • Refining treatment of metastatic breast cancer 
  • Early detection of metastatic breast cancer 
Applications that fit the focus areas as detailed in the LOI Announcement and include studies that address metastatic breast cancer disparities, or leverage data science to better understand and treat metastatic breast cancer are highly encouraged. The award provides funding up to $450,000 (direct and indirect costs combined) over 3 years. 

Application Deadline: September 25, 2019 
To Apply>> 
Learn More>> 

Alex's Lemonade Stand (ALSF) Single-Cell Pediatric Cancer Atlas
Alex’s Lemonade Stand Foundation (ALSF) is now accepting applications for the ALSF Single-cell Pediatric Cancer Atlas. ALSF seeks to build a Pediatric Cancer Atlas as an open resource for discovery with an initial goal of producing data that can be harmonized. ALSF seeks researchers to create datasets that profile pediatric cancers at a single-cell resolution level. Single-cell profiling can provide insights into the heterogeneity of cells in a tumor and the surrounding tumor microenvironment, as well as variability in the states of cancer cells, all of which can influence the cancer’s response to treatments.

Application Deadline: September 30, 2019
Learn More>>

Alex’s Lemonade Stand Foundation (ALSF) 2020 Crazy 8 Initiative Award

The Crazy 8 Initiative Award will fund research into innovative and rigorous approaches that directly address the most intractable issues in pediatric cancer research today. 

Application Deadline: October 1, 2019

Burroughs Wellcome Fund - Career Awards for Medical Scientists
The Career Awards for Medical Scientists (CAMS) is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in the area of basic biomedical, disease-oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are not eligible.

Application Deadline: October 1, 2019
Learn More>>

Life Sciences Research Foundation - Postdoctoral Research Fellowship
Since 1983, the Life Sciences Research Foundation (LSRF) has funded nearly 550 outstanding postdoctoral fellows in all areas of the life sciences, and raised more than $50 million from generous industries, foundations, and individuals to support this effort. 

Application Deadline: 8:00 PM EST on October 1, 2019
Learn More>> 

Cancer Research Institute - CRI Irvington Postdoctoral Fellowship Program Applications
The Cancer Research Institute is currently accepting applications for its CRI Irvington Postdoctoral Fellowship Program. The CRI Irvington Fellowship furthers career development and supports laboratory research for promising young scientists working under the mentorship of leading immunologists.

Program Note: In recent years, significant advances in immunotherapy have yielded major breakthroughs in cancer treatment. CRI recognizes, however, that getting to the next great breakthrough will require continued investment in fundamental research and training. With this in mind, CRI accepts applications from qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or tumor immunology.

CRI is seeking hypothesis-driven, mechanistic studies in both immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer.

Application Deadline:
October 1, 2019
Learn More>>

Defense Health Program  - Department of Defense Melanoma Research Program Funding Opportunities for Fiscal Year 2019 (FY19
The FY19 Defense Appropriation provides $10 million (M) to the Department of Defense (DoD) Melanoma Research Program (MRP) to support innovative, high-impact melanoma research. 
FY19 MRP Program Announcements and General Application Instructions for the following award mechanism is posted on the website.

The FY19 MRP Focus Areas are listed below:
Precursor Lesions, Melanomagenesis, Host Factors, and the Tumor Microenvironment (e.g., melanoma instigators, ultraviolet [UV] exposure, other instigators)
Melanoma Primary Tumor Evolution (e.g., dormancy, heterogeneity, metabolism, epigenetic dysregulation, cell death)
Therapeutic Prevention
Minimal Residual Disease
Rare Melanomas (e.g., uveal, acral, leptomeningeal disease, pediatric, adolescent and young adult [AYA], mucosal)

The MRP challenges the research community to redefine the concept of prevention and has issued a FY19 MRP Challenge Statement that should be considered when responding to the FY19 MRP Focus Areas and funding opportunities. 

Concept Award
Investigators at or above postdoctoral fellow (or equivalent)
• Supports the exploration of highly innovative, untested, potentially groundbreaking concepts in melanoma.
• Emphasis is on Innovation.
• Preliminary data is strongly discouraged.
• Clinical trials are not allowed.
• Blinded review.
• The maximum allowable funding for the entire period of performance is $75,000 in direct costs.
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• The maximum period of performance is 1 year.

LOI Deadline: October 2, 2019; Application Deadline: October 23, 2019
Learn More>> 

American Lung Association Lung Cancer Discovery Award
Intended to support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our current understanding of lung cancer and improving diagnostic, clinical and treatment methods. A Letter of Intent (LOI) is required for this award.

Letter of Intent (LOI) Deadline: October 3, 2019
Learn More>>

Maximizing the Scientific Value of Existing Biospecimen Collections (R21)
The purpose of this FOA is to invite R21 applications to stimulate exploratory research relevant to the mission of the FDA - Center for Tobacco Products using existing (publicly available) biospecimens currently stored in repositories in the United States.

Application Deadline: October 8, 2019 
Learn more about this R21 FDA Award>>

Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21)
The purpose of this FOA is to invite R21 applications proposing the innovative analysis of existing (publicly available) nationally representative U.S. cross-sectional and longitudinal data, to investigate novel scientific ideas and/or to generate new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the FDA- Center for Tobacco Products.

Application Deadline: October 8, 2019 
Learn more about this R21 FDA Tobacco Award> 

Pfizer Global Medical Grants (GMG) - 2019 Global Breast Cancer Competitive Research Grant Program 
The intent of this request for proposal (RFP) is to invite investigators from across the global to submit innovative proposals focusing in the following areas: 

In hormone receptor positive metastatic breast cancer: 
- Treatment strategies to overcome palbociclib + endocrine treatment resistance 
- Novel treatment concepts of adding immuno-oncology (IO) agents to palbociclib + endocrine therapy 
In metastatic breast cancer: 
- Novel treatment strategies utilizing talazoparib beyond gBRCA mutation 
- Novel treatment strategies to overcome talazoparib resistance or improve tumor sensitization to talazoparib 

Letter of Intent Deadline: October 15, 2019
Learn More>>

NIBIB Trailblazer Award for New and Early Stage Investigators (R21) 
This Trailblazer Award is an opportunity for New and Early Stage Investigators to pursue research programs of high interest to the NIBIB that integrate engineering and the physical sciences with the life and behavioral sciences. 

Application Deadline: October 16, 2019 
Learn more about this NIBIB Award>> 

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21) 
The purpose of this FOA is to provide support for the development of innovative interventions that improve cancer-related health behaviors across diverse racial/ethnic populations. 

Application Deadline: October 16, 2019 
Learn more about this NCI R21 Award>>  

2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research

This award provides greater New York City area-based early career scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking.

LOI's Due: November 4, 2019

Learn More about the Pershing Award>>

Terri Brodeur Breast Cancer Foundation Grant Program

This award is intended to support scientists at earlier stages of their careers to enable the development of independent programs and compelling careers in breast cancer research. 

Application Deadline: November 16, 2019

Learn More about the Terri Brodeur Grant>>